gefitinib has been researched along with 4-hydroxyquinazoline in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (4-hydroxyquinazoline) | Trials (4-hydroxyquinazoline) | Recent Studies (post-2010) (4-hydroxyquinazoline) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 104 | 0 | 66 |
| Protein | Taxonomy | gefitinib (IC50) | 4-hydroxyquinazoline (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase 2 | Mus musculus (house mouse) | 5.888 | |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 7.046 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aziz, AA; Al-Gendy, MA; El-Azab, AS; Ghabbour, HA | 1 |
1 other study(ies) available for gefitinib and 4-hydroxyquinazoline
| Article | Year |
|---|---|
Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
Topics: Acetamides; Amides; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Protein Binding; Quinazolines; Quinazolinones | 2017 |